Actively Recruiting
Registry and Biosample Repository for Cancer and Benign Tumor Patients Undergoing Radiotherapy
Led by Abramson Cancer Center at Penn Medicine · Updated on 2026-03-04
8000
Participants Needed
4
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are establishing a registry and biosample repository for patients aged 18 and older who have been diagnosed with cancer or benign tumors and are undergoing radiotherapy. This observational study aims to collect and store biological samples such as blood, urine, and tumor specimens to support future research. The study is sponsored by the Abramson Cancer Center at Penn Medicine and focuses on understanding health outcomes related to radiotherapy treatment. Participants contribute samples and health information during their radiotherapy treatment period. The study does not involve treatment interventions but collects biosamples and clinical data to build a resource for ongoing and future cancer research. The repository will enable researchers to study various aspects of tumor biology and treatment effects over time. Throughout participation, individuals will undergo health assessments that are tracked for up to 10 years. The study involves no additional treatment procedures but focuses on long-term monitoring of health outcomes. This extended follow-up helps to better understand patient health after radiotherapy. Total participation duration may vary depending on individual follow-up timelines.
CONDITIONS
Brief Title
The Radiation Oncology Registry and Biosample Repository
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosed with cancer or a benign tumor
- Undergoing radiotherapy treatment
- Able to sign consent form
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - During radiotherapy treatment
Participants provide biosamples for research related to cancer and benign tumors.
Visits coincide with routine radiotherapy sessions
Duration - Up to 10 years
Participants are monitored for health outcomes following radiotherapy treatment.
Periodic health assessments over 10 years
Trial Site Locations
Total: 4 locations
1
Virtua Samson Cancer Center
Moorestown, New Jersey, United States, 08057
Not Yet Recruiting
2
Virtua Health & Wellness Center
Voorhees Township, New Jersey, United States, 08043
Actively Recruiting
3
Lancaster General Hospital
Lancaster, Pennsylvania, United States, 17604
Actively Recruiting
4
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
P
Project Manager
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here